Pooled analysis of phase II window studies in children with contemporary high-risk metastatic rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.

Lager, Joanne J; Lyden, Elizabeth R; Anderson, James R; Pappo, Alberto S; Meyer, William H; Breitfeld, Philip P

Lager, Joanne J; Lyden, Elizabeth R; Anderson, James R; Pappo, Alberto S; Meyer, William H; Breitfeld, Philip P.

J Clin Oncol ; 24(21): 3415-22, 2006 Jul 20.

Article in En | MEDLINE | ID: mdl-16849756

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Rhabdomyosarcoma/drug therapy; Rhabdomyosarcoma/secondary; Adolescent; Camptothecin/administration & dosage; Camptothecin/analogs & derivatives; Child; Child, Preschool; Clinical Trials, Phase II as Topic; Cyclophosphamide/administration & dosage; Disease-Free Survival; Doxorubicin/administration & dosage; Enzyme Inhibitors/administration & dosage; Etoposide/administration & dosage; Female; Humans; Ifosfamide/administration & dosage; Irinotecan; Lymphatic Metastasis; Male; Survival Analysis; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Topotecan/administration & dosage; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Rhabdomyosarcoma / Antineoplastic Combined Chemotherapy Protocols Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Adolescent / Child / Child, preschool / Female / Humans / Male Language: En Journal: J Clin Oncol Year: 2006 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links